Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor
about
Ca2+ signalling in K562 human erythroleukaemia cells: effect of dimethyl sulphoxide and role of G-proteins in thrombin- and thromboxane A2-activated pathwaysDistinct biochemical properties of the native members of the G12 G-protein subfamily. Characterization of G alpha 12 purified from rat brainTwo thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutationRat kidney thromboxane receptor: molecular cloning, signal transduction, and intrarenal expression localizationPathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activationThe role of prostaglandins in allergic lung inflammation and asthmaRenal autoregulation in health and diseaseEndothelial 12(S)-HETE vasorelaxation is mediated by thromboxane receptor inhibition in mouse mesenteric arteriesThe 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variantsEvidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alphaHuman thromboxane A2 receptor genetic variants: in silico, in vitro and "in platelet" analysisThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsProstanoid receptor antagonists: development strategies and therapeutic applicationsThromboxane and the thromboxane receptor in cardiovascular disease.The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis.High-level expression, purification and characterization of a constitutively active thromboxane A2 receptor polymorphic variant.EP1- and FP-mediated cross-desensitization of the alpha (alpha) and beta (beta) isoforms of the human thromboxane A2 receptor.Molecular Architecture of G Protein-Coupled Receptors.Regulation of the tumor suppressor FOXO3 by the thromboxane-A2 receptors in urothelial cancerA novel thromboxane A2 receptor D304N variant that abrogates ligand binding in a patient with a bleeding diathesisBrain changes associated with thromboxane receptor antagonist SQ 29,548 treatment in a mouse modelThe Wilms' tumour suppressor protein WT1 acts as a key transcriptional repressor of the human thromboxane A2 receptor gene in megakaryocytes.Activation of thromboxane receptor alpha induces expression of cyclooxygenase-2 through multiple signaling pathways in A549 human lung adenocarcinoma cells.Flavonoids inhibit the platelet TxA(2) signalling pathway and antagonize TxA(2) receptors (TP) in platelets and smooth muscle cells.Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase.Putative role of prostaglandin receptor in intracerebral hemorrhage.Thromboxane A2 Receptor Inhibition Suppresses Multiple Myeloma Cell Proliferation by Inducing p38/c-Jun N-terminal Kinase (JNK) Mitogen-activated Protein Kinase (MAPK)-mediated G2/M Progression Delay and Cell Apoptosis.An eicosanoid-centric view of atherothrombotic risk factorsCharacterization of endothelial thromboxane receptors in rabbit aortaRole for the thromboxane A2 receptor β-isoform in the pathogenesis of intrauterine growth restriction.Differential regulation of RhoA-mediated signaling by the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor: independent modulation of TPalpha signaling by prostacyclin and nitric oxide.Thromboxane A2 receptor activates a Rho-associated kinase/LKB1/PTEN pathway to attenuate endothelium insulin signaling.Aspirin plus tirofiban inhibit the thrombosis induced by Russell's viper venomCoagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2Thromboxane receptor hyper-responsiveness in hypoxic pulmonary hypertension requires serine 324Inhibitors of the 5-lipoxygenase pathway activate pannexin1 channels in macrophages via the thromboxane receptor.Urinary thromboxane B2 and thromboxane receptors in bladder cancer: opportunity for detection and monitoringRegulation of GPCR expression through an interaction with CCT7, a subunit of the CCT/TRiC complex.Intermolecular cross-talk between the prostaglandin E2 receptor (EP)3 of subtype and thromboxane A(2) receptor signalling in human erythroleukaemic cells.Activation-dependent stabilization of the human thromboxane receptor: role of reactive oxygen species.
P2860
Q24528223-B28AA3A9-5E9C-4FBD-BC56-58E4E0CEDD6EQ24529952-DD08B40E-FD3E-4299-9B35-D52246385E40Q24562692-96837F8E-E0F6-4739-8E86-C9844DFB38DAQ24683299-ED05B4D2-19F6-47E9-A225-456CD5048E22Q26864770-CB5246EB-A2A1-4D04-ABAB-F5D5A4689DA3Q27024735-366189DE-869D-4401-A4E8-103E55DEFC7DQ28082365-BF045A3E-6C81-43A8-9E98-29AF158F160FQ28280471-C7C36292-4489-43FA-BE83-60BA80DCFB9BQ28368220-A7485186-1523-48E7-AE3B-D0CBFCDA8837Q28379254-FF8C63D4-8A65-4647-842E-C7D4781815BFQ28534432-78B1168A-9E54-44F9-8921-FCE901B6B2C9Q30486707-573CFD32-0015-4A81-AF0C-503DA82A7F04Q33485483-7A95E264-C911-422B-9483-44EFB514D36CQ33899567-AF2FC3B4-F968-45C0-BE38-9E8DAE528E0BQ34228685-376099BD-FA86-4AA5-8412-B3E151B6BB29Q35006368-73251662-A5E5-4377-8BEF-DCEDB981CC46Q35047084-31D31563-8F67-4C45-8874-60856FFDA0EEQ35210290-D16CE006-A383-4856-9013-2973ECF63971Q35244124-91C1A19C-09C7-471A-9E0C-B134E0593A13Q35517839-AC5351AC-EFB3-44C3-BBDC-2D64CD36094AQ35772240-249CF1BF-D846-418F-BBB0-6BD411B23F80Q35889126-7E490DE3-59C9-4B81-B4E8-CC85EE222C18Q36016888-375D4275-0D20-4ABA-BE26-63146B4AB05DQ36024622-2B30757D-9338-4E3A-AE22-5EDC01E229FFQ36058741-5269A58C-7360-4B94-BB82-25BCF1C47D2EQ36337569-17292552-ACE4-44AD-BBDE-52F1F44E62FDQ36744591-70B6BC53-536A-48F1-B547-D00E50C79476Q36952174-43A60AE7-2CBB-412A-8F90-9674D288E061Q36975599-92C7D559-C706-453D-8791-2C14D34050F1Q37057328-E0D034DE-E78E-4571-8970-22D525D9F7D4Q37189926-471FD95C-B7B3-403D-9212-6CF3BC4D693FQ37285129-36DF02B6-22E4-4C21-AD4E-64B3B7F3F234Q37324171-C104F7DA-E106-4C59-8811-F6305C0873F5Q37388131-DB430C70-9473-4F0A-9565-B86024A95873Q38550648-A741CD5F-FB8E-4B1F-BAD0-593E61BE78C7Q38969864-1CA3D9E4-92AB-4F90-87AC-ED78721BB004Q39097913-16FC9FE4-DB6B-44A5-9FC3-3BB38CD244F6Q39453304-34F4CC91-75FB-43A1-9151-E453BEAF4B41Q39809132-84B70528-E2BF-444B-BF20-6480F957C0FCQ39893903-CF51F797-7C5A-4FB6-9550-F4342E7E7321
P2860
Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor
description
1994 nî lūn-bûn
@nan
1994 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Alternative splicing produces ...... helial thromboxane A2 receptor
@ast
Alternative splicing produces ...... helial thromboxane A2 receptor
@en
Alternative splicing produces ...... helial thromboxane A2 receptor
@nl
type
label
Alternative splicing produces ...... helial thromboxane A2 receptor
@ast
Alternative splicing produces ...... helial thromboxane A2 receptor
@en
Alternative splicing produces ...... helial thromboxane A2 receptor
@nl
prefLabel
Alternative splicing produces ...... helial thromboxane A2 receptor
@ast
Alternative splicing produces ...... helial thromboxane A2 receptor
@en
Alternative splicing produces ...... helial thromboxane A2 receptor
@nl
P2093
P3181
P1476
Alternative splicing produces ...... helial thromboxane A2 receptor
@en
P2093
L J Collins
M K Raychowdhury
S H McGrail
P304
19256-19261
P3181
P407
P577
1994-07-01T00:00:00Z